RxDoctor Payments Data

Antoinette Gomes, MD

Vascular & Interventional Radiology · Los Angeles, CANPI 1013953835

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,475 of the $6,610 with a category attached, or 82.8%. 22 manufacturers reported payments, led by Penumbra, Inc. at 35.1% of the total. 2025 is the largest year on record at $2,223, 2.6 times the $861 reported in 2019.

$6,610in general payments, 2019–2025

Across 91 payments — averaging $72.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$2K
  • Trisalus Life Sciences, Inc.$1K
  • Boston Scientific$701
  • Sirtex Medical Inc$457
  • Angiodynamics, Inc.$336
  • Medtronic$332
  • plus $1K from 16 others
$85,687in research payments, 2019–2025

Across 18 payments — averaging $4760.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merit Medical Systems Inc$54K
  • Biocompatibles UK Ltd$31K
  • Boston Scientific$1K

What the payments were for

  • Travel & lodging$1,13517%
  • Food & beverage$5,47583%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,610 in reported general payments places this provider in the 65th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California →

Medicare billing

Part B allowed, 2024
$40,302
Medicare patients
92
Services billed
366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →